Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3047826	s-amh	ug/l (ug/l)	6290	7955	0.52%
3047826	s-amh	— (—)	787	1141	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Amenorrhoea

430

408

11.99

307.65

1.3

4.49

3.36

ug/l

2.37

383

372

Endometriosis of ovary

514

493

11.03

307.65

1.4

1.5

2.33

3.33

ug/l

1.40

484

378

Noninflammatory disorders of female genital tract

1779

1174

8.09

307.65

1.3

1.4

4.05

3.88

ug/l

0.10

1690

1020

Procreative management

1120

1717

5.82

307.65

1.4

1.3

3.23

3.61

ug/l

0.77

1041

1507

Endometriosis of pelvic peritoneum

446

546

8.49

307.65

1.3

1.5

2.19

4.59

ug/l

1.11

420

435

Female infertility, associated with anovulation

964

541

23.47

307.65

1.2

6.21

3.04

ug/l

21.36

939

494

Endometriosis diagnosis and infertility diagnosis occurring together

680

972

8.04

307.65

1.3

2.54

3.51

ug/l

1.37

648

860

Female infertility, cervigal, vaginal, other or unspecified origin

3205

934

28.83

307.65

1.3

1.4

2.99

3.87

ug/l

0.63

3068

800

Medical treatment for female infertility

2033

2737

9.08

307.65

1.3

1.2

3.13

3.19

ug/l

0.13

1950

2453

Endometriosis

887

885

6.20

307.65

1.3

1.4

2.46

3.93

ug/l

1.18

820

742

Polycystic ovarian syndrome, broad definition

1067

2341

5.50

307.65

1.2

6.63

2.80

ug/l

24.82

1039

2220

Female infertility

3467

991

26.87

307.65

1.3

1.4

3.57

3.91

ug/l

0.21

3332

853

Genitourinary diseases

834

812

5.23

301.71

1.3

1.4

4.27

5.20

ug/l

0.46

786

706

Female infertility, tubal origin

229

125

20.37

292.04

1.3

1.5

2.99

3.44

ug/l

0.15

216

Unspecified/other endometriosis

360

415

9.37

289.61

1.4

1.3

2.38

3.04

ug/l

1.20

335

356

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

196

117

18.13

238.63

4.5

1.2

20.94

2.82

ug/l

1.91

103

Ovarian cyst

686

1000

4.07

199.55

1.5

1.4

3.57

3.84

ug/l

0.10

598

852

Pain and other conditions associated with female genital organs and menstrual cycle

474

1009

4.67

194.54

1.3

2.69

3.90

ug/l

1.11

457

880

Ovarian dysfunction

548

1448

4.35

188.31

1.3

7.85

3.29

ug/l

9.96

478

1387

Endometriosis of rectovaginal septum and vagina

187

170

11.59

177.92

1.5

2.17

3.24

ug/l

0.66

175

129

Complications associated with artificial fertilization

137

22.34

176.57

1.3

1.2

4.91

4.10

ug/l

0.21

132

Excessive, frequent and irregular menstruation

709

1127

3.58

171.89

1.3

1.4

4.12

3.87

ug/l

0.12

645

976

Medicines for HER+ breast cancer

409

881

4.62

168.62

1.8

1.5

4.16

5.51

ug/l

0.57

297

639

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

246

351

7.09

159.89

3.8

1.2

16.36

2.89

ug/l

1.87

137

282

Disorders of other endocrine glands

832

3048

2.75

153.75

1.3

6.72

3.35

ug/l

8.94

732

2791

Polyp of the female genital tract

383

454

5.00

142.39

1.4

1.6

2.51

4.90

ug/l

0.73

316

327

L02BG Aromatase inhibitors

298

619

4.91

133.79

2.0

1.6

5.08

6.58

ug/l

0.41

218

435

Endometriosis ASRM stages 3,4

609

2100

3.02

131.81

1.4

1.3

2.37

3.59

ug/l

3.98

571

1859

Polycystic ovarian syndrome

422

1216

4.01

128.68

1.2

1.3

8.90

3.09

ug/l

12.70

413

1172

Oligomenorrhoea

141

139

11.08

127.79

1.4

1.2

4.51

3.83

ug/l

0.32

133

121

Endometriosis of intestine

100

19.87

123.73

1.4

1.3

2.18

4.35

ug/l

0.51

Malignant neoplasm of ovary

114

14.02

121.36

5.5

1.4

23.23

3.07

ug/l

1.39

Dysplasia of cervi uteri

416

879

3.75

120.97

1.3

1.4

3.61

3.90

ug/l

0.10

382

751

Adenomyosis (Endometriosis of uterus)

155

209

7.59

108.45

1.4

1.9

2.25

3.11

ug/l

0.54

135

139

Primary_lymphoid and hematopoietic malignant neoplasms

188

335

5.69

100.21

1.8

1.2

3.58

3.61

ug/l

0.01

151

294

Pregnancy examination and test

653

1677

2.55

90.45

1.2

1.3

4.23

3.34

ug/l

1.09

630

1525

Primary_lymphoid and hematopoietic malignant neoplasms

188

382

4.99

86.68

1.8

1.5

3.58

4.46

ug/l

0.38

151

319

malignant neoplasm of female genital organs

148

261

5.79

80.06

4.5

1.2

18.40

4.27

ug/l

1.19

199

Irregular menses

1154

5163

1.85

77.95

1.3

4.15

3.16

ug/l

2.18

1025

4701

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

208

402

4.24

73.68

1.3

1.1

1.66

2.11

ug/l

1.32

106

281

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

123

200

6.26

72.26

1.7

1.2

3.02

2.89

ug/l

0.05

171

Neoplasms

1488

4721

1.71

71.54

1.4

1.2

3.44

3.65

ug/l

0.41

1344

4514

Deep endometriosis

268

826

3.41

70.93

1.4

2.24

4.01

ug/l

2.74

253

744

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

838

2514

1.99

66.93

1.9

1.2

4.52

3.07

ug/l

1.05

597

2252

Malignant neoplasm, wide definition for exclusion

838

2519

1.98

66.56

1.9

1.2

4.52

3.05

ug/l

1.07

597

2257

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

838

2519

1.98

66.55

1.9

1.2

4.52

3.05

ug/l

1.07

597

2257

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

191

416

4.06

65.84

1.8

1.1

2.71

2.83

ug/l

0.06

129

330

Polycystic ovarian syndrome, consortium definition

1455

5331

1.67

65.69

1.3

4.97

3.18

ug/l

7.76

1308

4827

Malignant neoplasm of breast, HER-positive

204

550

3.69

63.53

1.4

1.7

1.54

7.44

ug/l

1.98

103

321

Malignant neoplasm

745

2205

2.02

62.42

1.9

1.2

3.72

3.35

ug/l

0.23

523

1921

Endometriosis ASRM stages 1,2

451

1966

2.37

60.84

1.3

2.21

3.50

ug/l

6.03

425

1758

Dental caries 2

1161

5487

1.68

57.00

1.3

3.31

3.68

ug/l

0.94

1079

4940

Persons encountering health services in circumstances related to reproduction

601

1967

2.09

56.98

1.4

4.88

4.33

ug/l

0.43

544

1688

Primary ovarian failure

103

187

6.26

55.81

1.5

1.4

1.22

2.92

ug/l

1.79

171

Supervision of high-risk pregnancy

579

1688

2.13

54.72

1.3

4.18

3.31

ug/l

1.77

545

1506

Hodgkin lymphoma

135

6.93

54.35

1.8

1.2

2.49

3.09

ug/l

0.77

125

Personal history of malignant neoplasm

132

6.88

54.04

2.1

1.5

2.45

3.09

ug/l

0.91

116

Benign neoplasm of ovary

171

479

3.63

51.87

2.2

1.2

4.11

3.31

ug/l

0.45

107

416

Hodgkin lymphoma, hilmo

142

6.58

51.76

1.8

1.3

2.49

3.07

ug/l

0.74

129

Other noninflammatory disorders of vulva and perineum

125

280

4.58

51.62

1.4

3.00

3.22

ug/l

0.16

116

230

Secondary uncertain malignant neoplasm

100

187

5.43

50.87

1.8

1.6

3.25

4.91

ug/l

0.43

153

Dental caries 2, only avohilmo

1139

5542

1.64

50.75

1.3

3.37

3.71

ug/l

0.80

1069

4984

Endocrine, nutritional and metabolic diseases

1343

4304

1.60

50.26

1.3

4.65

3.40

ug/l

3.40

1222

3958

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

320

809

2.61

49.64

1.4

1.1

1.63

2.83

ug/l

1.92

188

645

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

320

809

2.61

49.64

1.4

1.1

1.63

2.83

ug/l

1.92

188

645

Dental caries 2 and operation codes

1128

5549

1.63

49.59

1.3

3.30

3.70

ug/l

1.06

1047

5001

Secondary and unspecified malignant neoplasm of lymph nodes

160

5.82

49.57

1.9

1.4

3.36

2.98

ug/l

0.13

139

Other noninflammatory disorders of vagina

175

5.56

49.24

1.5

1.4

2.90

3.59

ug/l

0.37

138

Spontaneous abortion

986

4078

1.67

45.86

1.3

3.10

3.69

ug/l

1.55

918

3653

L02BA Anti-estrogens

141

380

3.77

45.29

1.9

1.5

1.69

4.17

ug/l

1.69

259

Hypothyroidism and >3 levothyroxin purchases

754

2437

1.81

44.91

1.3

1.2

3.36

3.55

ug/l

0.31

707

2335

Hypothyroidism, levothyroxine purchases

754

2437

1.81

44.91

1.3

1.2

3.36

3.55

ug/l

0.31

707

2335

Hypopituitarism

106

239

4.57

43.55

1.6

1.4

5.17

3.50

ug/l

0.50

217

Hypothyroidism (congenital or acquired)

750

2440

1.80

43.55

1.3

1.2

3.36

3.55

ug/l

0.33

705

2338

Malignant neoplasm of breast

313

936

2.43

43.36

1.5

1.6

1.63

5.00

ug/l

2.57

180

664

Malignant neoplasm of breast, HER2-negative

292

870

2.48

42.59

1.5

1.6

1.55

5.28

ug/l

2.56

165

600

Other abnormal products of conception

935

3839

1.66

41.58

1.3

3.23

3.37

ug/l

0.16

884

3486

Exclusions for E4_PCOS_BROAD

255

1018

2.56

41.54

1.4

3.77

4.62

ug/l

0.52

229

915

Special screening examination for infectious and parasitic diseases

663

2812

1.80

40.50

1.3

1.2

3.16

3.45

ug/l

1.16

629

2643

Disorders of the thyroid gland

1253

5418

1.52

39.92

1.3

3.06

3.70

ug/l

2.44

1132

4913

Benign neoplasm of ovary

171

565

3.08

39.89

2.2

1.5

4.11

5.01

ug/l

0.32

107

464

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

8.06

39.38

1.9

1.2

4.18

3.44

ug/l

0.18

Other noninflammatory disorders of uterus, except cervix

105

157

4.60

38.82

1.8

2.2

9.67

11.20

ug/l

0.07

Finngen Rheumatological endpoints

538

5452

0.56

37.81

1.4

1.3

3.50

3.55

ug/l

0.05

466

4921

Rare circulating lymphoid malignancy

7.32

36.27

1.9

1.5

4.18

3.60

ug/l

0.14

Any gastric operation

1273

4377

1.47

32.52

1.5

1.2

3.58

3.65

ug/l

0.10

1158

4083

GASTRO-related operations

1273

4377

1.47

32.52

1.5

1.2

3.58

3.65

ug/l

0.10

1158

4083

Other symptoms and signs involving the digestive system and abdomen

185

716

2.62

32.20

1.8

1.4

4.26

3.81

ug/l

0.14

118

622

Lymphoid leukaemia

6.20

31.50

2.0

1.2

4.25

3.37

ug/l

0.22

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

7.17

31.14

1.4

1.3

2.17

4.50

ug/l

0.65

Other menopausal disorders

121

195

3.60

30.96

1.3

2.2

1.09

11.43

ug/l

0.87

Hypothyroidism, other/unspecified

1163

5314

1.45

29.85

1.3

3.07

3.69

ug/l

2.18

1053

4812

Other abnormal uterine and vaginal bleeding

151

376

2.89

29.37

1.2

1.7

3.24

5.27

ug/l

0.48

129

278

Menorrhagia

270

672

2.24

29.25

1.4

1.5

2.41

4.22

ug/l

0.97

238

533

Uterine polyps

122

5.06

28.89

1.7

2.0

2.20

3.54

ug/l

0.41

Diabetes, insulin treatment (Kela reimbursement)

249

3127

0.48

28.31

1.4

3.33

3.98

ug/l

0.94

197

2657

Lymphoid leukaemia

5.57

28.25

2.0

1.4

4.25

3.44

ug/l

0.20

Hypothyreosis and Thyroxine purchase for inclusion criteria

1167

5432

1.43

27.12

1.3

3.06

3.66

ug/l

2.12

1057

4906

Neurotic, stress-related and somatoform disorders

1103

5494

1.44

26.92

1.3

3.36

3.73

ug/l

0.83

992

4949

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

248

3048

0.49

26.60

1.4

3.33

3.89

ug/l

0.73

197

2583

Anxiety disorders

1103

5495

1.43

26.44

1.3

3.36

3.73

ug/l

0.82

993

4948

Ovarian dysfunction, other/unspecified

8.37

26.39

1.7

1.2

2.12

2.75

ug/l

0.39

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

11.00

26.07

3.4

1.1

11.30

2.17

ug/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

6.62

25.81

1.7

1.3

2.55

4.57

ug/l

0.53

Other heart diseases, wide

442

4581

0.60

24.91

1.3

4.27

3.71

ug/l

0.14

363

4065

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

117

390

2.90

24.90

1.8

1.1

1.62

2.50

ug/l

4.12

303

Anxiety (asthma-related co-morbidities)

929

5100

1.45

24.04

1.3

3.39

3.73

ug/l

0.77

851

4641

Benign leiomyoma with endometriosis

287

3.24

23.79

1.3

1.1

2.05

2.31

ug/l

0.41

221

All anxiety disorders

953

5387

1.44

23.63

1.3

3.39

3.59

ug/l

0.44

874

4924

Exclusions for E4_PCOS_CONSORTIUM

1079

4826

1.41

23.44

1.7

1.2

4.34

3.35

ug/l

1.04

886

4456

Outcome of delivery

444

1634

1.72

22.69

1.2

1.3

4.47

3.29

ug/l

2.04

422

1472

Pain in throat and chest

417

4220

0.60

22.68

1.3

2.92

3.85

ug/l

2.27

360

3774

Diseases of oesophagus, stomach and duodenum

484

4687

0.62

22.36

1.4

1.3

4.34

3.53

ug/l

0.43

416

4151

Polyarthropathies

266

3287

0.54

22.27

1.4

1.3

4.37

3.66

ug/l

0.44

235

2916

Salpingitis and oophoritis

170

752

2.29

22.25

1.6

1.4

3.42

4.08

ug/l

0.17

144

593

Fall on same level

758

6163

0.68

22.23

1.3

3.62

3.73

ug/l

0.15

664

5587

Abnormalities of breathing

618

5537

0.66

21.99

1.3

3.28

3.77

ug/l

0.93

534

5051

Nerve, nerve root and plexus disorders

463

4651

0.62

21.77

1.3

3.17

3.50

ug/l

0.34

382

4121

Hypothyroidism, strict autoimmune

1003

4748

1.41

21.75

1.3

3.18

3.74

ug/l

1.55

912

4300

Postmenopausal bleeding

121

3.69

21.27

2.1

2.7

2.75

22.37

ug/l

0.60

Any event in cancer register

948

3986

1.42

21.10

1.8

1.2

3.90

3.17

ug/l

0.62

718

3659

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

111

4.54

20.97

1.9

1.1

4.17

2.99

ug/l

0.19

Serous carcinoma of ovary

8.17

20.95

3.4

1.9

11.30

2.54

ug/l

—

Congenital malformations of genital organs

241

1253

1.97

20.63

1.4

1.3

4.67

4.05

ug/l

0.27

217

1173

Deposits [accretions] on teeth

279

3.07

20.27

1.9

1.3

4.23

6.95

ug/l

1.01

262

Statin medication

188

2102

0.50

19.67

1.5

1.4

2.75

3.91

ug/l

1.42

130

1735

Influenza and pneumonia

613

5919

0.68

19.30

1.3

3.27

3.74

ug/l

1.30

532

5335

Autoimmune diseases excluding thyroid diseases, strict definition

615

5042

0.68

19.21

1.2

1.3

3.30

3.92

ug/l

1.92

549

4571

Other diseases of hard tissues of teeth

667

3391

1.47

19.14

1.4

1.3

3.26

3.96

ug/l

1.18

583

3019

Autoimmune diseases excluding thyroid diseases

635

5146

0.68

19.04

1.2

1.3

3.25

3.89

ug/l

2.08

568

4662

Parodontitis or/and operation codes

247

2659

0.55

19.01

1.6

1.3

2.56

3.30

ug/l

2.44

205

2353

Leiomyoma of uterus

438

1525

1.63

18.58

1.4

1.2

4.91

2.78

ug/l

0.90

331

1354

Cardiovascular diseases (excluding rheumatic etc)

641

5354

0.69

18.48

1.3

3.12

3.50

ug/l

0.70

553

4957

Other intervertebral disc disorders

349

3499

0.61

18.27

1.3

4.10

3.48

ug/l

0.23

278

3106

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

524

4918

0.66

18.24

1.4

1.3

3.08

3.73

ug/l

1.95

450

4437

524

4918

0.66

18.24

1.4

1.3

3.08

3.73

ug/l

1.95

450

4437

Cardiac arrhythmias

322

3500

0.60

17.36

1.4

1.3

4.86

3.56

ug/l

0.28

273

3105

Non-follicular lymphoma, hilmo, excluding all cancers

5.04

16.66

1.9

1.1

1.46

2.93

ug/l

2.13

Pneumonias (Asthma/COPD co-morbidities)

525

5324

0.68

16.42

1.4

1.3

3.35

3.76

ug/l

0.65

452

4768

All pneumoniae

534

5378

0.68

16.42

1.4

1.3

3.35

3.76

ug/l

0.65

460

4817

Routine general health check-up of defined subpopulation

164

3.57

16.42

2.0

1.3

2.46

4.50

ug/l

1.67

153

Benign neoplasms

1128

4845

1.32

16.39

1.4

1.2

3.39

3.52

ug/l

0.20

1013

4622

Artrosis, including avohilmo

226

2198

0.56

16.02

1.5

1.4

2.94

3.69

ug/l

0.45

175

1802

Chromosomal abnormalities, not elsewhere classified

192

3.35

15.98

1.5

1.4

4.85

3.62

ug/l

0.24

175

Ectopic pregnancy

263

1527

1.75

15.94

1.3

2.98

4.30

ug/l

1.65

241

1334

Disorders of gallbladder, biliary tract and pancreas

346

3538

0.63

15.94

1.3

1.4

2.64

3.55

ug/l

2.09

270

3053

Dental caries 2 and operation codes, only avohilmo

838

3804

1.38

15.88

1.3

3.25

3.62

ug/l

1.02

777

3438

Antenatal screening

480

1781

1.54

15.82

1.2

1.3

4.58

3.37

ug/l

2.54

449

1596

Tonsillectomy and adenotomy

1021

5389

1.33

15.72

1.3

3.56

3.53

ug/l

0.03

952

4948

Anxiety disorders, excluding more controls

937

4641

1.34

15.63

1.3

3.35

3.73

ug/l

0.84

834

4168

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1135

4951

1.31

15.58

1.4

1.3

3.79

3.76

ug/l

0.03

1002

4468

Triptan medication for migraine, single purchase ok

1039

5363

1.32

15.16

1.3

3.78

3.63

ug/l

0.13

943

4841

Migraine, single triptan purchase ok & required. ICD-code if available is included

1039

5363

1.32

15.16

1.3

3.78

3.63

ug/l

0.13

943

4841

Symptoms and signs involving cognition, perception, emotional state and behaviour

447

4652

0.67

15.14

1.4

1.3

3.23

3.74

ug/l

1.01

382

4114

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

494

5033

0.69

14.76

1.4

1.3

3.33

3.81

ug/l

0.77

423

4493

Inflammatory bowel disease treatment related agents

786

6001

0.74

14.43

1.4

1.3

2.91

3.78

ug/l

3.21

698

5424

Congenital malformations of uterus and cervix

337

2.66

14.40

1.3

3.54

3.33

ug/l

0.21

316

Cystitis

1120

5307

1.30

14.25

1.3

3.44

3.65

ug/l

0.36

1028

4780

Benign leiomyoma with endometriosis

380

2.44

14.23

1.3

1.6

2.05

4.25

ug/l

1.39

258

Postpartum care and examination

392

1634

1.56

13.98

1.2

1.3

3.23

3.20

ug/l

0.06

374

1497

Recurrent or chronic depression

543

2745

1.44

13.78

1.2

1.3

2.98

3.88

ug/l

2.16

491

2479

Oral corticosteroids

635

5279

0.73

13.63

1.4

1.3

2.78

3.65

ug/l

2.51

556

4724

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

4.35

13.58

2.6

1.2

34.31

3.40

ug/l

0.48

Non-follicular lymphoma

4.20

13.40

1.9

1.5

1.46

3.00

ug/l

2.04

Sleep disorders (combined)

424

4072

0.68

13.37

1.4

1.3

4.10

3.59

ug/l

0.38

340

3562

Malignant neoplasm of breast, HER-negative

367

2.41

13.30

1.8

1.7

1.58

6.16

ug/l

1.85

245

Sleep apnoea, including avohilmo

268

2800

0.62

13.27

1.4

3.90

3.73

ug/l

0.07

194

2342

Asthma/COPD (KELA code 203)

619

5972

0.73

13.21

1.4

1.3

3.61

3.76

ug/l

0.16

553

5395

Family history of malignant neoplasm

144

746

1.96

12.75

1.5

1.3

2.75

4.24

ug/l

1.58

116

665

Other obstetric conditions, not elsewhere classified

1006

5103

1.30

12.68

1.2

1.3

3.29

3.40

ug/l

0.27

949

4747

Other specific joint derangements/joint disorders

614

5571

0.74

12.19

1.3

3.68

3.64

ug/l

0.02

534

5115

Agranulocytosis

340

2.41

12.19

1.8

1.5

2.55

4.31

ug/l

1.11

289

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

998

5084

1.29

12.13

1.2

1.3

3.28

3.40

ug/l

0.29

944

4738

Substance abuse, excluding more controls

215

3092

0.61

12.00

1.2

1.3

4.79

3.67

ug/l

0.32

188

2819

Hypothyroidism, strict autoimmune, 3 medication purchases required

997

5331

1.28

11.91

1.3

3.17

3.62

ug/l

1.16

896

4807

Pain in limb

505

5069

0.72

11.88

1.4

1.3

3.15

3.73

ug/l

1.01

434

4599

Cholelithiasis, broad definition with cholecystitis

304

3171

0.65

11.77

1.3

1.4

2.67

3.65

ug/l

1.96

242

2701

Transplanted organ and tissue status

222

2.73

11.70

1.9

1.5

3.50

5.23

ug/l

0.39

195

Arthrosis

157

1544

0.56

11.68

1.6

1.4

3.50

3.83

ug/l

0.11

119

1227

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

162

3.04

11.68

1.5

1.1

2.01

2.55

ug/l

0.45

120

Pneumonia, organism unspecified

422

4350

0.70

11.62

1.4

1.3

3.35

3.83

ug/l

0.64

362

3864

Medical abortion

619

4508

0.74

11.32

1.3

3.39

3.77

ug/l

0.30

558

4055

Codeine or tramadol medication

807

5782

0.77

11.30

1.4

1.3

3.73

3.52

ug/l

0.16

728

5221

Persons encountering health services for specific procedures and health care

687

5610

0.76

11.26

1.5

1.3

3.65

3.72

ug/l

0.05

585

5059

Cholelithiasis

291

3102

0.66

11.25

1.3

1.4

2.76

3.66

ug/l

1.64

228

2636

Use of hypnotics and sedatives

531

4203

0.73

11.18

1.4

1.3

2.70

3.55

ug/l

2.54

441

3704

ILD medications: prednisolone, methylprednisolone, prednisone

779

5691

0.77

10.91

1.4

1.3

2.86

3.78

ug/l

2.98

684

5147

Postprocedural endocrine and metabolic disorders, not elsewhere classified

133

710

1.90

10.81

2.0

1.4

1.95

3.80

ug/l

3.69

620

Congenital malformations of ovaries, fallopian tubes and broad ligaments

133

720

1.90

10.56

1.5

1.3

4.56

3.57

ug/l

0.24

116

668

Spondylopathies

189

1896

0.60

10.50

1.4

1.5

3.41

3.96

ug/l

0.24

133

1568

Disorders of tooth development and eruption

108

530

2.03

10.48

1.8

1.3

4.54

5.55

ug/l

0.29

511

Lower back pain or/and sciatica

666

6042

0.76

10.46

1.3

3.00

3.62

ug/l

1.84

570

5474

Other complications of labour and delivery, not elsewhere classified

462

3240

1.41

10.40

1.2

3.56

3.33

ug/l

0.46

448

3075

Intracranial trauma

400

4205

0.71

10.35

1.3

4.12

3.84

ug/l

0.14

364

3834

Malignant neoplasm of mesothelium and soft tissue

4.44

10.28

2.2

1.5

41.58

3.21

ug/l

0.45

Single spontaneous delivery

390

2933

0.70

10.11

1.2

1.3

4.75

3.36

ug/l

1.48

365

2673

Other metabolic disorders

137

755

1.83

10.09

2.0

1.4

2.03

3.75

ug/l

3.46

102

659

Other septicaemia

161

912

1.74

10.02

1.6

1.4

4.12

4.89

ug/l

0.29

128

794

Other diseases of intestines

786

5816

0.78

9.81

1.3

3.01

3.77

ug/l

3.30

694

5278

Disorders of puberty, all

230

2.61

9.71

1.6

1.4

7.50

3.96

ug/l

1.14

217

Other arrhythmias

242

2823

0.65

9.64

1.4

2.84

3.76

ug/l

2.03

202

2435

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

273

1816

1.51

9.59

1.4

3.51

4.03

ug/l

0.32

239

1573

Leiomyoma of uterus

452

1849

1.40

9.55

1.5

1.4

4.91

3.30

ug/l

0.58

333

1477

Melanocytic naevi

299

2032

1.48

9.49

1.3

1.2

3.70

3.49

ug/l

0.19

257

1893

199

2811

0.63

9.43

1.3

3.33

3.84

ug/l

0.90

178

2548

Other soft tissue disorders, not elsewhere classified

712

5628

0.78

9.38

1.3

3.05

3.79

ug/l

2.10

630

5141

Sleep apnoea

212

2242

0.64

9.32

1.5

1.4

4.27

3.92

ug/l

0.12

147

1809

Enlarged lymph nodes

140

796

1.77

9.31

1.7

1.3

3.49

4.05

ug/l

0.42

118

714

Hernia

333

3224

0.70

9.30

1.6

1.4

3.29

3.82

ug/l

0.66

268

2774

Non-invasive ventilation

1216

0.44

9.28

1.5

1.3

4.07

3.81

ug/l

0.05

1086

Parodontitis or operation codes

275

2981

0.68

9.17

1.7

1.4

2.54

3.85

ug/l

3.35

216

2525

Malignant neoplasm of other connective and soft tissue

6.02

9.15

1.9

1.3

1.82

3.19

ug/l

—

Parodontitis

275

2979

0.68

9.10

1.7

1.4

2.54

3.85

ug/l

3.35

216

2523

Mental and behavioural disorders due to psychoactive substance use

224

3214

0.66

9.01

1.2

1.3

4.76

3.63

ug/l

0.34

196

2925

Low back pain

506

5166

0.75

8.98

1.3

2.89

3.59

ug/l

2.98

442

4717

Hypertensive diseases

240

2054

0.66

8.98

1.8

1.3

3.73

3.77

ug/l

0.01

170

1673

ILD medications

870

5946

0.80

8.92

1.4

1.3

2.94

3.81

ug/l

3.11

773

5394

Renal tubulo-interstitial diseases

483

4938

0.75

8.92

1.4

1.3

3.72

3.76

ug/l

0.03

405

4436

Injuries to the knee and lower leg

851

6071

0.80

8.86

1.4

1.3

3.71

3.68

ug/l

0.04

742

5504

Chronic periodontitis, including avohilmo

274

2965

0.68

8.86

1.7

1.4

2.52

3.86

ug/l

3.41

215

2509

Donors of organs and tissues

3.60

8.78

1.2

1.3

3.31

3.35

ug/l

0.02

Hypertension

240

2042

0.66

8.74

1.8

1.3

3.73

3.74

ug/l

0.00

170

1661

Disorders of puberty

176

2.74

8.73

1.6

1.4

8.42

3.46

ug/l

1.33

169

Hypertensive diseases (excluding secondary)

219

1944

0.65

8.67

1.7

1.3

3.55

3.42

ug/l

0.06

166

1663

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

4.42

8.63

2.6

1.2

1.69

3.35

ug/l

1.02

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

4.39

8.60

1.6

1.1

2.19

3.00

ug/l

0.37

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

807

5270

1.26

8.55

1.2

1.3

3.31

3.48

ug/l

0.15

737

4756

Diabetes medication

584

4600

0.77

8.54

1.4

1.3

4.97

3.53

ug/l

5.49

522

4054

Diabetes mellitus

607

4671

0.77

8.52

1.4

1.3

4.89

3.52

ug/l

4.97

541

4128

Codeine

788

5413

0.80

8.43

1.4

1.3

3.78

3.58

ug/l

0.14

714

4940

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

4.46

8.36

1.6

1.1

2.19

3.02

ug/l

0.37

183

2620

0.64

8.32

1.3

3.29

3.85

ug/l

0.96

164

2375

Postpartum hemorraghe, parous women as controls

531

3558

1.32

8.28

1.2

1.3

3.88

3.53

ug/l

0.18

490

3260

Suicide or other Intentional self-harm

120

2055

0.58

8.20

1.2

1.3

3.05

3.71

ug/l

1.09

107

1875

Chronic diseases of tonsils and adenoids

929

4783

1.23

8.15

1.3

3.51

3.84

ug/l

0.65

848

4316

Shoulder lesions

205

1916

0.65

8.15

1.5

1.4

2.39

4.07

ug/l

2.63

147

1569

Tramadol

340

3037

0.72

8.13

1.7

1.3

2.74

3.49

ug/l

0.86

281

2643

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

331

3005

0.72

8.09

1.7

1.4

3.42

3.59

ug/l

0.10

250

2549

Headache

760

5082

1.25

8.09

1.4

1.3

4.11

3.71

ug/l

0.33

676

4619

Dyspnoea

411

4230

0.74

8.06

1.4

1.3

3.23

3.74

ug/l

0.62

342

3738

Gestational diabetes (for exclusion)

914

5284

1.24

8.04

1.2

1.3

3.39

3.31

ug/l

0.19

865

4848

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

3.85

7.96

1.8

1.1

0.49

2.36

ug/l

—

Substance abuse

215

3066

0.67

7.95

1.2

1.3

4.79

3.62

ug/l

0.34

188

2792

Antihypertensive medication - note that there are other indications

840

5662

0.81

7.94

1.3

3.20

3.60

ug/l

0.95

781

5253

Other disorders of urethra and urinary system

434

4325

0.75

7.93

1.3

3.28

3.71

ug/l

0.57

383

3832

Other disorders of ear

304

2852

0.71

7.92

1.5

1.4

3.18

4.12

ug/l

0.96

251

2426

Benzodiazepine use

629

5678

0.79

7.91

1.4

1.3

3.05

3.56

ug/l

1.48

536

5116

Insulin medication

176

2341

0.64

7.90

1.3

3.75

3.86

ug/l

0.11

152

2071

Benign neoplasms

1160

5392

1.20

7.89

1.4

1.3

3.35

3.61

ug/l

0.43

1037

5014

Chronic lower respiratory diseases

909

6011

0.82

7.88

1.3

3.31

3.76

ug/l

1.02

822

5430

Unspecified mental disorder

217

3216

0.67

7.82

1.3

3.39

3.62

ug/l

0.30

186

2933

Other diseases of blood and blood-forming organs, wide

121

697

1.75

7.75

1.7

1.4

2.48

4.15

ug/l

2.28

599

Follow-up examination after treatment for malignant neoplasms

134

2.78

7.63

2.8

1.7

1.97

8.22

ug/l

0.87

Molar incisor enamel hypoplasia

369

2.06

7.59

1.7

1.4

5.84

5.47

ug/l

0.07

347

Congenital malformations, deformations and chromosomal abnormalities

757

5860

1.24

7.55

1.4

1.3

3.84

3.53

ug/l

0.33

679

5378

Fever of other and unknown origin

474

3351

1.32

7.52

1.5

1.3

3.47

3.78

ug/l

0.37

406

3025

Short stature, not elsewhere classified

248

2.27

7.44

1.7

1.4

11.61

4.41

ug/l

1.19

237

Parodontitis and operation codes

259

2865

0.70

7.33

1.6

1.4

2.55

3.91

ug/l

3.32

206

2417

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

3.14

7.32

1.6

1.2

5.01

2.78

ug/l

0.32

Injuries to the head

769

6160

0.81

7.29

1.4

1.3

3.80

3.70

ug/l

0.08

691

5560

Diabetes, varying definitions

603

4550

0.79

7.21

1.4

1.3

4.91

3.55

ug/l

4.80

538

4010

Hypoplasia of dental enamel , including avohilmo

339

2.08

7.19

1.7

1.4

6.12

5.37

ug/l

0.13

319

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

270

3776

0.71

7.16

1.2

1.3

3.00

3.40

ug/l

1.23

247

3499

Drug-induced neutropenia

163

2.54

7.09

2.2

1.5

1.27

4.61

ug/l

1.29

134

Kela-code for severe mental illness

168

2567

0.65

7.09

1.2

1.3

3.50

3.73

ug/l

0.23

140

2330

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

270

3764

0.71

7.02

1.2

1.3

3.00

3.47

ug/l

1.42

247

3501

Pregnancy with abortive outcome

1045

4559

1.20

7.01

1.3

3.65

3.78

ug/l

0.13

973

4105

Injuries to the shoulder and upper arm

299

3450

0.72

6.99

1.2

1.4

3.24

4.14

ug/l

1.96

255

3031

Hypertension, essential

218

1808

0.69

6.78

1.9

1.4

3.74

ug/l

0.00

143

1443

Septicaemia

170

1063

1.54

6.73

1.7

1.4

4.13

4.95

ug/l

0.35

135

923

Dorsalgia

839

5501

0.82

6.68

1.3

2.98

3.65

ug/l

2.59

734

5037

Used for control exclusion in common control thyroid runs

1154

4943

1.19

6.64

1.3

3.52

3.91

ug/l

0.92

1052

4491

Cardiovascular diseases

858

5632

0.83

6.56

1.3

3.25

3.63

ug/l

1.03

775

5258

Other disorders involving the immune mechanism, not elsewhere classified

107

2.85

6.45

1.6

1.2

4.89

2.69

ug/l

0.34

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

102

1698

0.60

6.39

1.2

1.3

2.67

3.84

ug/l

3.00

1574

Benign neoplasm of other and unspecified endocrine glands

323

1.99

6.30

1.3

1.2

2.24

3.05

ug/l

1.67

282

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

287

3536

0.73

6.30

1.3

4.50

3.97

ug/l

0.50

271

3389

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

173

2.39

6.29

1.9

1.2

3.07

2.99

ug/l

0.05

154

Insulin, combination of fast acting with intermediate-acting or long-acting

176

2394

0.68

6.24

1.3

3.75

3.97

ug/l

0.22

152

2122

Dermatitis and eczema

1043

5782

1.19

6.24

1.3

3.42

3.69

ug/l

0.46

941

5208

Depression

972

5632

1.19

6.20

1.3

3.03

3.75

ug/l

3.59

875

5082

Melanocytic naevi

299

2205

1.36

6.17

1.3

3.70

3.68

ug/l

0.01

257

1997

Infections of genitourinary tract in pregnancy

1559

0.59

6.11

1.2

1.3

3.53

3.33

ug/l

0.21

1463

Alcohol use disorder, Swedish definition

158

2199

0.67

6.10

1.3

3.24

3.85

ug/l

0.87

142

1963

Type 2 diabetes, wide definition

123

1275

0.63

6.09

1.6

1.5

2.48

4.76

ug/l

2.01

968

Condition for Implicit Sepsis (Organ dysfunction codes)

347

3320

0.76

6.02

1.5

1.3

3.33

4.03

ug/l

1.17

296

2926

Schizophrenia or delusion, excluding more controls

143

2157

0.65

5.98

1.5

1.3

3.77

3.71

ug/l

0.05

122

1968

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

227

2023

0.71

5.98

1.5

1.3

3.76

3.45

ug/l

0.14

168

1747

Other diseases of urinary system

1109

5314

1.18

5.98

1.3

3.41

3.65

ug/l

0.42

1011

4785

Personality disorders, excluding more controls

227

3164

0.71

5.98

1.4

1.2

3.08

3.41

ug/l

0.79

206

2937

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

117

2.66

5.97

2.3

1.1

1.71

2.35

ug/l

0.61

Appendectomy

669

5281

1.22

5.94

1.7

1.3

5.34

3.26

ug/l

0.97

565

4771

Undescended testicle

15.26

5.92

2.2

1.0

16.86

39.02

ug/l

—

Other endocrine disorders

408

1.85

5.90

1.7

1.3

9.21

3.99

ug/l

1.10

387

Conjunctivitis

832

6067

1.20

5.89

1.3

3.40

3.77

ug/l

0.76

751

5475

Mental and behavioural disorders due to alcohol

168

2401

0.68

5.87

1.2

1.3

3.29

3.58

ug/l

0.44

149

2174

Disorders of adult personality and behaviour

247

3386

0.72

5.87

1.3

3.46

3.60

ug/l

0.12

223

3149

Abnormal findings in secretions and smears from cervix uteri vagina vulva

798

5228

1.21

5.87

1.2

1.3

3.30

3.47

ug/l

0.15

729

4721

Malignant neoplasm of kidney, except renal pelvis

3.79

5.81

1.8

1.40

3.20

ug/l

1.12

Melanocytic naevi of trunk

110

674

1.65

5.77

1.2

3.36

3.79

ug/l

0.33

629

Intestinal infectious diseases

909

5980

1.19

5.65

1.4

1.3

3.32

3.74

ug/l

1.43

815

5420

Certain disorders involving the immune mechanism

100

602

1.67

5.59

1.7

1.4

5.21

3.77

ug/l

0.34

501

Personality disorders

227

3124

0.72

5.56

1.4

1.3

3.08

3.54

ug/l

1.11

206

2905

Schizophrenia or delusion

143

2139

0.67

5.56

1.5

1.3

3.77

3.66

ug/l

0.09

122

1938

Schizophrenia, schizotypal and delusional disorders

143

2138

0.67

5.55

1.5

1.3

3.77

3.66

ug/l

0.09

122

1938

Malignant neoplasm of urinary organs

3.63

5.47

1.8

1.40

3.20

ug/l

1.12

Poisoning by drugs, medicaments and biological substances

162

2352

0.68

5.43

1.2

1.3

2.95

3.71

ug/l

2.05

147

2169

Intestinal stricture

510

1.71

5.37

1.2

1.5

1.80

4.78

ug/l

2.04

405

Carpal tunnel syndrome

178

2292

0.70

5.32

1.3

1.4

2.31

3.91

ug/l

2.90

139

1872

Inflammatory diseases of female pelvic organs

903

5788

1.18

5.29

1.4

1.3

3.09

3.62

ug/l

0.89

803

5237

Other heart diseases

263

2329

0.74

5.21

1.4

1.3

5.11

3.96

ug/l

0.17

209

2065

Other maternal disorders predominantly related to pregnancy

915

4896

1.18

5.20

1.2

1.3

4.11

3.55

ug/l

0.73

847

4398

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

373

2900

1.28

5.18

1.4

2.98

3.77

ug/l

0.82

307

2515

Gonarthrosis [arthrosis of knee](FG)

102

956

0.63

5.11

1.8

1.6

4.48

4.84

ug/l

0.06

630

Symptoms and signs involving the digestive system and abdomen

946

4035

1.18

5.10

1.4

1.3

4.32

3.80

ug/l

0.48

840

3672

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

2.61

5.08

1.7

1.1

2.46

2.95

ug/l

0.25

Disturbance of activity and attention

116

1741

0.65

5.05

1.2

1.3

4.94

4.00

ug/l

0.40

111

1653

Examination and observation for other reasons

597

2975

1.22

5.05

1.4

1.3

3.53

3.99

ug/l

0.56

532

2706

Other anxiety disorders

708

5266

1.20

5.02

1.3

3.47

3.53

ug/l

0.09

659

4874

Hyperkinetic disorders

122

1808

0.66

4.99

1.2

1.3

4.89

4.13

ug/l

0.33

117

1715

Poisoning by medicine

150

2169

0.69

4.97

1.2

1.3

3.02

3.73

ug/l

1.68

137

2001

Specific personality disorders

203

2786

0.72

4.95

1.3

3.04

3.60

ug/l

1.37

183

2590

Rheumatoid arthritis

1193

0.60

4.94

1.2

1.4

2.97

4.33

ug/l

0.98

984

Insulin, fast-acting (human)

1151

0.58

4.85

1.3

4.40

3.81

ug/l

0.36

1073

Gonarthrosis

884

0.63

4.83

1.8

1.5

4.66

4.94

ug/l

0.05

614

Postpartum haemorrhage

531

3792

1.23

4.83

1.2

1.3

3.88

3.33

ug/l

0.33

490

3471

Disorders of conjunctiva

849

6069

1.17

4.82

1.3

3.37

3.77

ug/l

0.85

767

5477

Other other unspecified disorders of the circulatory system

3.81

4.82

2.3

1.9

2.74

6.31

ug/l

—

Benign neoplasm of bone and articular cartilage

364

1.80

4.78

1.8

1.2

5.42

3.15

ug/l

0.56

333

Abdominal and pelvic pain

938

4035

1.17

4.78

1.3

4.38

3.80

ug/l

0.55

835

3672

Lumbar disc prolapse

265

2776

0.76

4.78

1.3

1.4

4.63

3.61

ug/l

0.31

212

2406

Benign neoplasm of other and unspecified female genital organs

151

2.28

4.75

1.6

1.1

2.30

2.76

ug/l

0.52

135

Insulin, intermediate and long-acting

143

2031

0.69

4.74

1.3

1.4

3.85

4.13

ug/l

0.24

123

1799

Carcinoma in situ of breast, intraductal

108

2.51

4.70

1.9

1.1

19.79

2.81

ug/l

0.44

Other and unspecified nonorganic psychotic disorders

108

1645

0.65

4.69

1.4

1.3

3.96

3.82

ug/l

0.09

1517

Hyperkinetic disorders, excluding more controls

122

1758

0.67

4.68

1.2

4.89

3.95

ug/l

0.44

117

1687

Persons encountering health services in other circumstances, wide

1099

4951

1.15

4.66

1.4

1.3

3.79

3.76

ug/l

0.03

973

4468

Other disorders of adrenal gland

199

2.09

4.62

1.3

1.4

2.56

2.74

ug/l

0.16

179

Atopic dermatitis

781

5679

1.18

4.59

1.3

3.73

3.57

ug/l

0.21

718

5193

Disorders of choroid and retina

181

1828

0.72

4.57

1.5

1.4

7.63

3.95

ug/l

0.48

151

1513

L04AD Calcineurin inhibitors

377

1.76

4.55

1.6

1.4

3.57

4.51

ug/l

0.26

328

Other and unspecified tonsillitis

416

4360

0.81

4.50

1.3

1.2

3.38

3.62

ug/l

0.38

386

4121

Other bacterial intestinal infections

570

1.60

4.44

1.5

1.4

4.22

4.11

ug/l

0.03

499

Benign neoplasm of other and unspecified endocrine glands

366

1.76

4.40

1.3

1.5

2.24

3.89

ug/l

1.38

304

Diabetic retinopathy, excluding more controls

492

0.54

4.35

1.3

1.4

3.42

5.08

ug/l

3.10

437

Gestational [pregnancy-induced] hypertension

326

4101

0.79

4.34

1.3

4.37

3.08

ug/l

0.96

294

3739

Mental and behavioural disorders due to alcohol, excluding acute intoxication

120

1759

0.68

4.32

1.1

1.3

3.23

3.76

ug/l

0.65

106

1578

Melanocytic naevi of trunk

110

726

1.53

4.31

1.2

1.3

3.36

3.90

ug/l

0.52

670

Malignant melanoma, excluding all cancers (controls excluding all cancers)

204

2.02

4.30

1.1

2.65

2.68

ug/l

0.02

172

Colorectal cancer, excluding all cancers (controls excluding all cancers)

133

2.26

4.30

2.0

1.1

2.31

2.50

ug/l

0.06

Other anaemias

130

855

1.47

4.29

1.7

1.4

3.00

4.41

ug/l

1.26

100

709

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

338

2676

1.27

4.25

1.3

1.4

2.95

3.87

ug/l

0.90

280

2306

Other and unspecified anaemias

127

836

1.47

4.23

1.7

1.4

3.02

4.46

ug/l

1.26

694

Benign neoplasm: Colon, unspecified

152

2.16

4.17

1.5

1.1

3.31

2.42

ug/l

0.52

111

Mood [affective] disorders

983

5636

1.15

4.16

1.3

2.98

3.75

ug/l

4.02

874

5083

Emotionally unstable personality disorder

135

1912

0.70

4.12

1.3

3.31

3.78

ug/l

0.68

122

1801

Aplastic and other anaemias

145

966

1.43

4.09

1.7

1.4

2.97

4.31

ug/l

1.36

115

809

Mood disorders

983

5636

1.15

4.09

1.3

2.98

3.75

ug/l

4.02

874

5083

Concussion

371

3970

0.81

4.06

1.3

4.22

3.90

ug/l

0.14

340

3617

Diabetes mellitus in pregnancy

824

4621

1.16

4.02

1.2

1.3

3.66

3.27

ug/l

1.19

785

4247

Melanocytic naevi of other and unspecified parts of face

304

1.79

3.98

1.3

1.2

3.00

3.29

ug/l

0.23

284

Other degenerative diseases of the nervous system

829

0.61

3.94

1.3

2.80

4.08

ug/l

1.11

722

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

261

1.85

3.94

1.5

1.2

2.13

2.82

ug/l

0.74

228

Dental caries

194

1430

1.35

3.93

1.7

1.3

3.79

4.30

ug/l

0.24

162

1310

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

3.64

3.92

2.6

1.1

0.80

2.91

ug/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

3.64

3.92

2.6

1.1

0.80

2.91

ug/l

—

Reimbursement for rheumatic diseases

239

3083

0.77

3.89

1.3

1.4

3.45

3.89

ug/l

0.29

203

2658

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

2.88

3.89

2.0

1.1

3.06

2.51

ug/l

—

Metabolic disorders

351

2705

0.80

3.84

1.8

1.4

2.57

4.11

ug/l

3.81

269

2282

Anosmia

3.41

3.83

1.5

1.1

4.15

3.95

ug/l

0.02

Conductive and sensorineural hearing loss

166

1568

0.73

3.83

1.6

1.5

3.78

4.78

ug/l

0.43

127

1251

Rheumatoid arthritis, including avohilmo

1428

0.67

3.77

1.2

1.4

2.77

4.01

ug/l

1.50

1185

Meniscus derangement

127

1234

0.70

3.76

1.2

1.4

2.57

4.28

ug/l

1.48

965

Diseases of pulp and periapical tissues, including avohilmo

921

5464

0.87

3.75

1.3

3.52

3.80

ug/l

0.52

828

4971

Inguinal hernia

129

1231

0.71

3.74

1.3

3.84

4.10

ug/l

0.16

115

1105

Abnormal findings on antenatal screening of mother

170

2272

0.74

3.73

1.2

1.3

2.99

3.19

ug/l

0.41

156

2152

Bacterial infection, other or unspecified

197

1334

1.33

3.73

1.5

1.4

3.26

4.41

ug/l

0.88

158

1132

Sub-endpoint used in defining T1D endpoints

134

1840

0.71

3.72

1.3

4.16

4.06

ug/l

0.07

122

1692

Dizziness and giddiness

331

3328

0.81

3.70

1.4

3.12

3.79

ug/l

1.23

279

2893

Dental pulpitis 1

922

5464

0.87

3.69

1.3

3.52

3.80

ug/l

0.53

829

4971

Delivery

463

2943

0.83

3.68

1.3

4.87

3.36

ug/l

2.04

431

2682

Malignant neoplasm of respiratory system and intrathoracic organs

2.51

3.67

1.8

2.2

2.69

9.25

ug/l

0.73

Benign neoplasm of other and unspecified female genital organs

169

2.03

3.66

1.6

1.5

2.30

4.74

ug/l

0.90

146

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

621

5223

1.17

3.64

1.3

3.47

3.70

ug/l

0.31

568

4691

Diabetic retinopathy

544

0.58

3.64

1.3

1.4

3.43

4.89

ug/l

2.56

478

Autoimmune diseases

1148

5202

1.13

3.62

1.3

3.48

3.88

ug/l

0.99

1047

4717

Allergic conjunctivitis

644

5442

1.17

3.62

1.3

3.46

3.68

ug/l

0.29

585

4887

Asthma, unspecified (mode), excluding more controls

294

2889

0.80

3.62

1.5

1.3

2.87

3.78

ug/l

3.12

265

2563

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

230

1.76

3.58

1.9

1.1

2.01

2.43

ug/l

0.30

158

Excessive attrition of teeth

425

1897

1.22

3.58

1.3

1.2

3.65

3.68

ug/l

0.03

386

1728

Artificial joint operation, meniscal resection

171

1527

0.74

3.56

1.7

1.5

4.26

4.58

ug/l

0.10

125

1178

Personal history of certain other diseases

320

0.33

3.55

1.4

1.2

2.25

3.63

ug/l

1.11

304

Benign neoplasm of bone and articular cartilage

399

1.64

3.54

1.8

1.3

5.42

3.89

ug/l

0.32

362

Dental pulpitis 4

925

5461

0.88

3.53

1.3

3.52

3.80

ug/l

0.53

831

4969

Complications of labour and delivery

895

4374

1.14

3.52

1.3

3.96

3.60

ug/l

0.32

814

3930

Acute upper respiratory infections of multiple and unspecified sites

801

5235

1.15

3.51

1.3

3.32

3.74

ug/l

1.07

738

4754

Alcohol use disorder, ICD-based

117

1652

0.71

3.49

1.1

1.3

3.24

3.81

ug/l

0.67

103

1484

Exposure to unspecified factor

690

6181

0.86

3.49

1.3

4.25

3.64

ug/l

0.54

619

5574

169

2238

0.75

3.48

1.3

2.64

3.38

ug/l

2.74

161

2104

Other congenital malformations

115

804

1.44

3.47

1.6

1.3

5.39

4.11

ug/l

0.43

106

750

Acute upper respiratory infections

960

5304

1.14

3.47

1.3

3.37

3.74

ug/l

0.85

859

4764

Dental caries 1, only avohilmo

460

2816

0.83

3.46

1.4

1.3

3.34

3.89

ug/l

0.68

407

2496

Complications of medical and surgical care

467

3718

1.19

3.46

1.4

1.3

2.89

3.70

ug/l

1.15

382

3256

Disorders of lipoprotein metabolism and other lipidaemias

113

1013

0.70

3.43

1.8

1.6

3.27

5.17

ug/l

1.06

736

Asthma, unspecified (mode)

294

2896

0.80

3.42

1.5

1.3

2.87

4.00

ug/l

2.93

265

2565

Gonarthrosis,primary

788

0.66

3.42

2.0

1.7

5.54

5.75

ug/l

0.03

453

Iron deficiency anaemia secondary to blood loss (chronic)

364

1.65

3.41

1.6

1.5

4.85

4.06

ug/l

0.10

300

Intestinal adhesions without obstruction

113

2.22

3.41

1.3

1.9

2.24

6.18

ug/l

0.82

Bacterial intestinal infections, IBD co-morbidities

569

1.52

3.40

1.6

1.4

4.07

4.11

ug/l

0.01

497

Other disorders of the genitourinary system

224

1.84

3.36

1.6

1.7

5.97

5.09

ug/l

0.07

165

Myeloid leukaemia

3.27

3.35

1.3

1.6

2.75

3.51

ug/l

—

Explicit Sepsis

220

1638

1.29

3.34

1.6

1.3

3.78

4.21

ug/l

0.23

182

1452

Other joint disorders

929

5597

0.88

3.33

1.3

3.62

3.72

ug/l

0.08

829

5140

Prolonged pregnancy

297

3335

0.80

3.32

1.2

1.3

3.62

3.09

ug/l

1.77

277

3116

Haemorrhage from respiratory passages

117

765

1.42

3.32

1.6

1.5

4.09

4.71

ug/l

0.20

645

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

182

1.93

3.32

1.1

2.69

2.64

ug/l

0.04

151

L01XE Protein kinase inhibitors

2.93

3.30

1.2

1.5

12.18

2.97

ug/l

—

Multiple delivery

998

0.63

3.28

1.9

1.3

4.59

2.67

ug/l

1.39

879

Maternal care for other conditions predominantly related to pregnancy

314

3788

0.81

3.28

1.2

1.3

4.16

3.12

ug/l

0.50

285

3476

Type 1 diabetes, wide definition

121

1675

0.72

3.28

1.3

4.12

3.91

ug/l

0.16

110

1543

Dental pulpitis 1, only avohilmo

934

5510

0.88

3.27

1.3

3.51

3.76

ug/l

0.46

842

5001

Substance use, excluding alcohol

1300

0.68

3.26

1.3

7.26

3.65

ug/l

0.44

1201

Type 2 diabetes

513

3584

0.85

3.25

1.4

5.08

3.48

ug/l

4.80

453

3091

Female genital prolapse

284

1.57

3.25

1.4

1.9

6.04

7.16

ug/l

0.09

171

Complications of the puerperium, not elsewhere classified

612

1.50

3.23

1.2

1.3

3.27

3.65

ug/l

0.32

567

Disorders of lens

658

0.64

3.22

1.5

1.7

18.42

5.07

ug/l

0.42

435

Varicose veins

949

0.68

3.22

2.2

1.5

5.70

5.44

ug/l

0.03

648

Dental caries 1

453

2755

0.84

3.22

1.4

1.3

3.54

3.89

ug/l

0.35

402

2448

Hard cardiovascular diseases

785

0.67

3.21

2.3

1.6

4.97

5.92

ug/l

0.17

538

Dental caries, including avohilmo

453

2754

0.84

3.20

1.4

1.3

3.54

3.90

ug/l

0.35

402

2447

Oxicams

101

823

0.70

3.17

1.3

2.04

3.90

ug/l

1.73

753

Foreign body on external eye

403

1.59

3.17

1.3

2.95

3.54

ug/l

0.61

367

Dental pulpitis 4, only avohilmo

935

5500

0.89

3.15

1.3

3.51

3.80

ug/l

0.54

841

4996

Melanocytic naevi of other and unspecified parts of face

327

1.67

3.15

1.3

1.4

3.00

4.25

ug/l

0.78

301

Oxycodone

583

1.48

3.15

1.8

1.5

4.48

4.19

ug/l

0.05

437

Bipolar affective disorders

157

2074

0.75

3.13

1.2

1.3

2.89

3.71

ug/l

2.08

139

1923

Motor disorders, excluding more controls

119

2.13

3.12

1.7

1.4

5.80

7.97

ug/l

0.41

114

Other and unspecified immunodeficiencies with predominantly antibody defects

2.86

3.11

2.7

1.3

16.04

3.41

ug/l

0.65

Type 1 diabetes, wide definition, subgroup 1

119

1636

0.72

3.11

1.3

4.13

3.94

ug/l

0.15

109

1508

Specific developmental disorder of motor function

123

2.12

3.10

1.7

1.5

5.80

8.21

ug/l

0.45

117

Other medical care

188

1413

1.30

3.09

1.9

1.4

5.04

4.12

ug/l

0.19

154

1227

Colectomy operation

260

1.74

3.09

2.0

1.5

4.92

4.08

ug/l

0.15

206

Maternal care for known or suspected disproportion

453

0.48

3.08

2.4

1.3

5.52

2.75

ug/l

0.43

392

Motor disorders

126

2.10

3.04

1.7

1.5

5.80

7.46

ug/l

0.30

118

Postmenopausal atrophic vaginitis

131

1.84

3.04

1.2

2.5

1.90

19.77

ug/l

0.64

Injuries to the wrist and hand

749

6167

0.88

3.03

1.3

3.51

3.73

ug/l

0.34

687

5561

Insulin, fast-acting or short human

141

1883

0.75

3.03

1.3

3.99

3.98

ug/l

0.01

122

1709

Insulin, fast-acting

141

1882

0.75

3.02

1.3

3.99

3.98

ug/l

0.01

122

1708

Schizoaffective disorder

491

0.51

3.02

1.2

1.3

3.08

3.90

ug/l

0.49

451

Seropositive rheumatoid arthritis

820

0.62

3.00

1.1

1.5

3.34

4.23

ug/l

0.42

648

Diseases of middle ear and mastoid

793

5741

1.13

2.97

1.3

3.92

3.47

ug/l

0.52

736

5343

Need for immunization against other single viral diseases

2.86

2.93

1.8

1.3

2.81

3.32

ug/l

0.20

Haemorrhoids and perianal venous thrombosis

108

771

1.40

2.92

1.2

1.5

3.41

5.00

ug/l

1.11

653

Type 1 diabetes

135

1800

0.75

2.91

1.3

4.14

3.92

ug/l

0.16

123

1651

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

2.83

2.91

2.5

1.1

0.70

2.98

ug/l

—

Exposure to other specified factors

506

5510

0.86

2.90

1.3

3.35

3.88

ug/l

0.98

462

4977

Diseases of the musculoskeletal system and connective tissue

721

4118

0.88

2.90

1.3

3.98

4.03

ug/l

0.03

659

3825

Direct fill therapy

100

707

1.42

2.89

1.9

1.4

5.12

4.34

ug/l

0.17

642

Benign neoplasm: Sigmoid colon

102

2.16

2.86

1.7

1.1

27.01

2.62

ug/l

0.53

Alcohol dependence

599

0.57

2.85

1.2

1.4

3.34

4.04

ug/l

0.29

524

Iron deficiency anaemia

235

1864

1.25

2.84

1.3

1.4

3.64

3.89

ug/l

0.13

209

1625

Disorders of refraction and accommodation

291

2379

1.22

2.84

1.4

1.3

3.89

4.03

ug/l

0.12

268

2185

Other retinal disorders

132

1419

0.75

2.84

1.5

4.44

4.05

ug/l

0.17

109

1193

Other and unspecified iron deficiency

205

1618

1.27

2.82

1.3

3.76

3.77

ug/l

0.01

189

1424

Bronchitis

995

5853

1.12

2.81

1.3

3.26

3.72

ug/l

1.36

907

5268

Biological medicines for asthma

0.00

2.80

0.0

1.3

—

3.22

—

Benign neoplasm of other and ill-defined parts of digestive system

262

1.68

2.75

1.5

1.2

4.13

2.75

ug/l

1.09

219

Adalimumab

590

0.57

2.74

1.2

1.4

2.66

3.94

ug/l

1.44

544

Dental caries 3

542

3201

0.86

2.73

1.4

1.3

4.19

3.95

ug/l

0.13

484

2866

Ischemic heart diseases

642

0.67

2.71

2.1

1.7

1.98

6.99

ug/l

2.00

400

Malignant neoplasm of corpus uteri

2.60

2.70

2.2

2.4

0.54

9.67

ug/l

—

Other specified/unspecified arthritis

110

1493

0.73

2.68

1.5

1.3

6.13

3.85

ug/l

0.71

1303

Senile cataract

383

0.58

2.67

1.6

2.0

41.36

7.34

ug/l

0.42

198

Other coagulation defects

471

1.50

2.66

1.7

1.3

3.14

4.06

ug/l

0.59

434

Dental caries 3, only avohilmo

551

3245

0.87

2.66

1.4

1.3

4.18

3.93

ug/l

0.13

492

2899

Any event in hilmo or specialist outpatient

4.85

2.66

1.3

1.0

4.54

2.76

ug/l

—

Factors influencing health status and contact with health services

162

619

1.32

2.65

1.4

1.3

3.37

4.47

ug/l

0.78

143

536

Cholecystectomy

257

2774

0.82

2.64

1.3

1.4

2.79

3.79

ug/l

1.57

200

2309

COPD/asthma/ILD related infections

885

4952

0.89

2.64

1.3

3.39

3.74

ug/l

0.74

778

4470

COPD/asthma related infections

885

4952

0.89

2.64

1.3

3.39

3.74

ug/l

0.74

778

4470

Artificial opening status

2.22

2.64

1.2

1.4

2.15

3.84

ug/l

1.77

Coronary revascularization (ANGIO or CABG)

196

0.39

2.62

1.5

1.9

1.49

8.13

ug/l

—

121

Paralytic ileus and intestinal obstruction

439

1.51

2.62

1.2

1.6

1.64

5.31

ug/l

2.22

347

Other dorsopathies, not elsewhere classified

940

5517

0.90

2.62

1.3

3.42

3.67

ug/l

0.26

838

5052

Acute tubulo-interstitial nephritis

386

4022

0.85

2.61

1.3

3.74

3.73

ug/l

0.00

329

3642

Other embolism and thrombosis

305

1.61

2.61

1.4

2.54

3.82

ug/l

0.71

256

Hypermetropia

449

1.50

2.60

1.6

1.4

3.74

4.98

ug/l

0.91

418

Nutritional anaemias

249

1976

1.23

2.58

1.3

1.4

3.58

3.85

ug/l

0.15

220

1712

Use of cabergoline

2.27

2.57

1.3

2.63

2.81

ug/l

0.11

Other/unspecified seropositive rheumatoid arthritis

776

0.64

2.55

1.1

1.5

3.38

4.09

ug/l

0.33

624

Emergency coronary revascularization (for ACS)

199

0.40

2.55

1.5

1.9

1.49

7.91

ug/l

—

126

Contraceptive management

307

1794

1.21

2.54

1.3

4.31

3.79

ug/l

0.18

261

1549

Behavioural syndromes associated with physiological disturbances and physical factors

475

4114

1.16

2.52

1.4

1.3

3.99

3.60

ug/l

0.43

444

3836

Presence of other functional implants

508

0.63

2.52

2.4

1.8

23.73

5.57

ug/l

0.41

339

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

773

0.65

2.51

1.1

1.5

3.38

4.09

ug/l

0.33

624

Seropositive rheumatoid arthritis, wide

785

0.65

2.51

1.1

1.5

3.34

4.06

ug/l

0.35

632

Maternal care for known or suspected abnormality of pelvic organs

419

3361

0.86

2.49

1.2

1.3

3.48

3.08

ug/l

1.17

391

3079

Long labour

477

3620

1.16

2.44

1.3

3.39

3.26

ug/l

0.19

448

3310

Dental pulpitis 2, only avohilmo

434

2583

0.86

2.43

1.4

1.3

3.57

3.91

ug/l

0.30

384

2298

Voice disturbances

137

1050

1.31

2.43

1.5

1.4

3.19

3.67

ug/l

0.21

114

882

Other symptoms and signs involving the nervous and musculoskeletal systems

211

2597

0.81

2.42

1.3

3.54

3.82

ug/l

0.17

178

2313

Carcinoma in situ of breast, intraductal

145

1.87

2.41

1.9

1.8

19.79

5.97

ug/l

0.34

Heart failure, not strict

920

0.73

2.40

1.7

1.6

12.10

4.55

ug/l

0.33

668

Coxarthrosis [arthrosis of hip](FG)

467

0.62

2.39

1.5

1.8

3.34

7.81

ug/l

0.88

253

Hallux valgus (acquired)

813

0.71

2.39

1.8

1.5

2.37

5.15

ug/l

1.55

601

Benign neoplasm: Colon

405

1.44

2.36

1.4

1.1

11.22

2.68

ug/l

0.55

309

Other complications of surgical and medical care, not elsewhere classified

451

1.47

2.36

1.6

1.4

4.81

3.81

ug/l

0.19

401

Coxarthrosis

419

0.61

2.33

1.6

1.8

3.34

8.34

ug/l

0.98

243

Rotator cuff syndrome

116

1138

0.76

2.33

1.5

2.46

4.88

ug/l

1.87

843

Disorders of eyelid, lacrimal system and orbit

409

3717

0.86

2.32

1.3

1.4

3.02

3.79

ug/l

1.09

339

3233

Depression medications

557

2456

1.14

2.32

1.3

1.2

3.51

3.55

ug/l

0.04

519

2353

Family history of certain disabilities and chronic diseases leading to disablement

546

1.43

2.31

1.4

1.3

3.06

3.59

ug/l

0.64

515

Astigmatism

429

1.48

2.30

1.5

1.4

3.94

4.81

ug/l

0.45

396

Benign neoplasm of breast

570

1.41

2.29

1.6

1.2

2.79

3.26

ug/l

0.64

516

Effects of foreign body entering through natural orifice

137

1060

1.30

2.29

1.4

1.3

3.24

4.35

ug/l

1.45

124

969

STROKE

908

0.74

2.26

2.0

1.5

4.04

5.86

ug/l

0.50

675

Malignant melanoma

208

1.69

2.26

1.1

1.6

2.63

4.55

ug/l

0.71

161

Major coronary heart disease event

392

0.61

2.26

2.2

1.9

2.17

6.34

ug/l

1.21

224

Malignant neoplasm of eye, brain and central nervous system

113

1.96

2.26

1.8

1.3

3.02

2.83

ug/l

0.08

Other arthritis (FG)

130

1675

0.77

2.24

1.4

5.59

3.91

ug/l

0.59

117

1448

Erosion of teeth, including avohilmo

224

1778

1.22

2.24

1.4

1.2

3.60

3.71

ug/l

0.07

208

1631

Dentinal caries

151

1181

1.28

2.24

1.6

1.3

4.44

ug/l

0.00

125

1078

Dental caries 3 and operation codes, only avohilmo

297

1773

0.84

2.23

1.4

1.3

3.39

3.71

ug/l

0.63

269

1624

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

5.62

2.22

1.0

1.1

—

0.97

—

Benign neoplasm: Colon, unspecified

194

1.70

2.21

1.5

1.8

3.31

4.74

ug/l

0.35

131

Maternal care for known or suspected fetal abnormality and damage

412

3182

1.16

2.21

1.2

1.3

3.31

3.07

ug/l

0.56

395

2962

Enterocolitis due to Clostridium difficile

248

1.62

2.21

2.0

1.4

2.59

4.15

ug/l

0.70

211

Arthropathies

1003

5604

0.91

2.20

1.3

3.63

3.76

ug/l

0.12

906

5147

False labour

545

3873

0.88

2.20

1.2

1.3

4.48

3.29

ug/l

1.23

511

3561

Colonic or urogenital fistula

130

1005

1.30

2.20

1.3

1.4

2.95

4.06

ug/l

1.16

112

864

All dysplastic lesions of the vagina

136

1.86

2.19

1.4

1.5

1.95

3.42

ug/l

0.82

117

Other surgical follow-up care

234

1.64

2.19

1.3

1.4

3.55

3.41

ug/l

0.08

220

Coagulation defects, purpura and other haemorrhagic conditions

137

1068

1.29

2.18

1.5

1.4

3.47

4.10

ug/l

0.55

125

962

Dental pulpitis 2

435

2564

0.87

2.17

1.4

1.3

3.56

3.92

ug/l

0.33

385

2284

Other skin changes

509

1.42

2.17

1.3

1.5

2.32

4.23

ug/l

2.43

442

Mood disorders, excluding more controls

843

4637

1.11

2.15

1.3

2.98

3.72

ug/l

3.04

741

4164

Seborrhoeic keratosis

250

1.60

2.14

1.3

1.7

2.64

6.54

ug/l

0.88

170

Diseases of arteries, arterioles and capillaries

915

0.74

2.14

1.9

1.5

2.92

4.72

ug/l

1.43

725

Persistent mood disorders

1289

0.75

2.13

1.2

1.3

2.67

4.07

ug/l

2.53

1164

Intrahepatic Cholestasis of Pregnancy (ICP)

1067

0.72

2.13

1.3

2.93

3.81

ug/l

1.07

988

Thrombocytopenia, unspecified

197

1.68

2.12

1.4

3.49

2.88

ug/l

0.46

174

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

643

4886

0.89

2.11

1.5

1.3

4.26

3.66

ug/l

0.23

539

4372

Right hemicolectomy

2.57

2.09

3.5

1.2

15.17

2.30

ug/l

—

Dental caries 1 and operation codes, only avohilmo

229

1390

0.83

2.08

1.3

1.2

3.42

3.64

ug/l

0.33

207

1264

General symptoms and signs

1108

5088

1.09

2.07

1.4

1.3

3.76

3.72

ug/l

0.04

981

4622

Benign neoplasm: Brain, infratentorial

3.58

2.07

1.7

1.5

2.34

2.36

ug/l

—

ILD medications: immunosuppressive drugs

362

4012

0.86

2.07

1.4

1.3

2.90

3.92

ug/l

2.25

318

3533

Constipation

344

2863

0.86

2.06

1.4

3.64

4.19

ug/l

0.48

279

2423

Melanocytic naevi, other sites/unspecified

407

1.46

2.05

1.4

1.2

2.46

3.27

ug/l

1.06

377

Dentofacial anomalies [including malocclusion]

314

2656

1.17

2.05

1.5

1.3

3.57

4.01

ug/l

0.40

285

2401

Parodontitis, operation under 40 years and operation codes

172

2110

0.81

2.04

1.3

1.2

2.86

3.43

ug/l

1.43

164

2027

L04AX Other immunosuppressants

272

3208

0.85

2.04

1.4

3.01

3.98

ug/l

1.45

244

2800

Fracture of lower leg, including ankle

218

2611

0.83

2.03

1.7

1.4

3.85

4.15

ug/l

0.17

190

2281

Problems related to lifestyle

863

0.70

2.03

1.4

1.3

2.99

3.67

ug/l

0.64

818

Parodontitis, under 40 years and operation codes

172

2108

0.81

2.03

1.3

1.2

2.86

3.43

ug/l

1.44

164

2025

Candidiasis

111

853

1.31

2.01

1.3

2.46

3.66

ug/l

2.45

103

773

Autoimmune diseases related-to ILD

577

5680

0.89

2.01

1.3

2.95

3.69

ug/l

1.82

508

5093

Supervision of normal pregnancy

356

1752

1.17

2.00

1.3

4.60

3.35

ug/l

1.75

327

1568

Other female pelvic inflammatory diseases

141

1118

1.27

2.00

1.4

1.3

2.50

4.01

ug/l

2.08

120

974

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1077

0.74

1.98

1.3

2.93

3.80

ug/l

1.06

990

Dorsopathies

994

5539

0.91

1.98

1.3

3.60

3.76

ug/l

0.16

899

5073

Birth injury to peripheral nervous system

3.11

1.98

1.4

1.2

3.23

2.95

ug/l

—

Benign neoplasm: Skin of eyelid, including canthus

256

1.57

1.97

1.5

1.1

2.48

2.79

ug/l

0.21

215

Thyroiditis, ILD-related definition

120

935

1.29

1.97

1.4

1.3

3.85

4.07

ug/l

0.07

106

850

Triptan medication for migraine, min. 3 purchases

816

5860

1.10

1.94

1.3

3.18

3.62

ug/l

1.17

738

5350

Complications of anaesthesia during pregnancy

0.00

1.94

0.0

1.1

—

3.26

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1049

0.74

1.94

1.3

2.93

4.06

ug/l

1.54

973

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

396

4464

0.87

1.93

1.3

3.38

3.56

ug/l

0.25

365

4146

Parodontitis, under 40 years, or operation codes

182

2203

0.82

1.91

1.3

1.2

2.86

3.40

ug/l

1.43

172

2113

Parodontitis, under 40 years

182

2202

0.82

1.90

1.3

1.2

2.86

3.40

ug/l

1.43

172

2112

Coronary atherosclerosis

370

0.64

1.90

3.0

2.0

2.81

6.81

ug/l

0.95

198

Sensorineural hearing loss

136

1196

0.80

1.90

1.5

2.40

5.28

ug/l

2.81

912

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1.96

1.89

1.7

1.1

2.95

2.68

ug/l

0.07

Perineal laceration during delivery

469

3709

1.13

1.88

1.2

3.50

3.33

ug/l

0.32

443

3484

Parasetamol

961

4491

1.09

1.88

1.4

1.3

4.15

3.72

ug/l

0.39

863

4160

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

530

0.64

1.88

1.3

3.59

3.56

ug/l

0.02

504

Other disorders of fluid, electrolyte and acid-base balance

497

1.38

1.87

1.5

2.35

5.05

ug/l

1.60

389

Obstructed labour due to malposition and malpresentation of fetus

408

3380

1.14

1.87

1.3

3.43

3.21

ug/l

0.38

376

3068

Other disorders of lacrimal gland

188

1551

1.21

1.86

1.3

1.4

2.41

3.95

ug/l

3.03

154

1322

Benign neoplasm: Adrenal gland

2.09

1.86

1.4

1.1

1.28

2.96

ug/l

—

Soft tissue disorders related to use, overuse and pressure

721

0.69

1.86

1.3

1.5

5.58

4.19

ug/l

0.25

575

Second line medication for Crohn's disease

293

3405

0.86

1.86

1.4

3.00

3.92

ug/l

1.51

265

2987

Open wound of wrist and hand

249

2902

0.85

1.85

1.3

3.66

3.72

ug/l

0.04

229

2667

Supplementary factors related to causes of morbidity and mortality classified elsewhere

152

1872

0.81

1.85

1.7

1.3

5.65

3.74

ug/l

0.40

134

1704

Childhood allergy (age < 16)

348

3283

0.87

1.84

1.2

1.3

4.43

4.10

ug/l

0.37

333

3175

Other problems related to primary support group, including family circumstances

180

1446

1.22

1.83

1.5

1.3

4.29

4.22

ug/l

0.04

165

1347

Asthma (diagnoses ohter than nonallergic)

636

6020

0.90

1.83

1.4

1.3

3.41

3.78

ug/l

0.59

573

5417

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

546

5326

0.89

1.83

1.3

4.66

3.32

ug/l

0.84

478

4803

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1062

0.75

1.83

1.3

2.93

4.05

ug/l

1.53

976

Implicit Sepsis

269

2446

0.85

1.82

1.5

1.4

3.59

3.94

ug/l

0.40

226

2150

Injuries to the elbow and forearm

446

4545

0.89

1.81

1.3

3.29

4.14

ug/l

2.63

396

4080

Duodenal ulcer

2.27

1.80

1.2

1.6

2.52

3.31

ug/l

—

Acute sinusitis

450

4723

0.89

1.79

1.3

3.70

3.50

ug/l

0.18

398

4295

Haemangioma, any site

287

1.50

1.79

1.5

1.2

2.85

3.07

ug/l

0.14

259

Temporomandibular joint disorders, including avohilmo

597

5376

1.11

1.79

1.3

2.90

3.59

ug/l

2.40

552

4931

Obesity due to excess calories

369

4204

0.88

1.78

1.3

3.76

3.51

ug/l

0.26

334

3809

Injuries to the thorax

123

1543

0.80

1.78

1.8

1.4

5.96

3.89

ug/l

0.36

112

1359

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

2.34

1.77

1.5

1.7

0.80

2.92

ug/l

—

Anaemias

344

1990

1.15

1.76

1.3

1.2

3.55

3.57

ug/l

0.01

299

1896

Mycoses

159

1299

1.23

1.76

1.3

4.41

3.57

ug/l

0.16

142

1159

Hyperhidrosis

281

1.51

1.76

1.2

1.3

3.24

3.70

ug/l

0.29

263

Malignant melanoma of skin

162

1.67

1.74

1.0

1.5

2.63

4.99

ug/l

0.69

127

Crossbite

525

1.35

1.74

1.7

1.4

5.46

5.37

ug/l

0.02

489

Acute alcohol intoxication

1010

0.75

1.73

1.3

3.34

4.06

ug/l

0.83

931

Zoster [herpes zoster]

447

1.39

1.73

1.7

1.4

2.33

4.24

ug/l

2.17

379

Benign neoplasm of mouth and pharynx

257

1.52

1.73

1.2

2.05

3.04

ug/l

2.34

225

Vulvovaginal ulceration/inflammation in other diseases

110

867

1.28

1.72

1.4

1.3

2.52

3.90

ug/l

2.38

812

Other disorders of amniotic fluid and membranes

256

2949

0.85

1.72

1.2

1.3

2.98

3.00

ug/l

0.04

235

2739

Pure hypercholesterolaemia

779

0.77

1.71

1.9

1.6

3.75

5.88

ug/l

0.83

550

Other neurological diseases

209

1992

0.84

1.69

1.7

1.4

3.50

4.20

ug/l

0.38

163

1681

Stroke, including SAH

577

0.72

1.69

2.3

1.7

5.71

5.13

ug/l

0.08

399

Haemorrhage in early pregnancy

428

3713

1.13

1.68

1.3

3.12

3.19

ug/l

0.12

396

3340

Localized swelling, mass and lump of skin and subcutaneous tissue

170

1406

1.21

1.68

1.4

3.22

4.17

ug/l

0.80

148

1232

Other specified and unspecified personality disorders

785

0.72

1.67

1.3

3.90

4.26

ug/l

0.18

726

Biological medication for rheuma

1160

0.77

1.66

1.2

1.3

2.79

3.99

ug/l

1.65

1058

Infections of the skin and subcutaneous tissue

355

4015

0.88

1.66

1.3

3.11

3.86

ug/l

2.22

316

3640

Benign neoplasm: Rectum, anus and anal canal

134

1.72

1.65

2.2

1.1

2.60

2.68

ug/l

0.04

101

Appendicitis, broad definition

519

5270

0.90

1.65

1.3

4.30

3.41

ug/l

0.46

454

4723

Thyrotoxicosis, other and/or unspecified

151

1238

1.22

1.64

1.2

1.3

2.47

4.02

ug/l

2.53

131

1099

Cerebrovascular diseases

890

0.78

1.64

1.9

1.6

4.33

4.26

ug/l

0.02

658

Diseases of appendix

522

5278

0.90

1.63

1.3

4.28

3.42

ug/l

0.44

457

4731

Pregnancy hypertension

523

5224

0.90

1.62

1.4

1.3

3.88

3.38

ug/l

0.45

459

4727

Acute alcohol intoxication, ICD10

975

0.76

1.61

1.3

3.37

4.34

ug/l

1.02

910

Tumor necrosis factor alpha inhibitors

1075

0.77

1.61

1.2

1.3

2.84

4.06

ug/l

1.54

981

Focal epilepsy

1030

0.76

1.60

1.2

1.4

2.68

4.55

ug/l

2.86

927

In situ neoplasms

222

1802

1.18

1.60

1.2

6.20

3.15

ug/l

0.69

194

1669

Benign neoplasm: Stomach

1.87

1.60

1.1

1.2

3.88

2.76

ug/l

—

Gastro-oesophageal reflux disease

260

2664

0.86

1.58

1.4

3.98

3.90

ug/l

0.03

217

2247

Other inflammation of vagina/vulva

509

1.35

1.58

1.2

1.3

2.52

3.18

ug/l

1.01

474

Type of accident

137

1672

0.82

1.58

1.7

1.3

5.79

3.84

ug/l

0.36

119

1512

Other disorders of the musculoskeletal system and connective tissue

337

0.59

1.56

1.3

1.5

2.17

4.20

ug/l

1.13

272

Cyst of kidney

2.11

1.55

1.0

1.6

3.46

2.71

ug/l

—

Anomalies of dental arch relationship, including avohilmo

234

1804

1.17

1.54

1.5

1.3

4.76

4.15

ug/l

0.41

213

1682

Other diseases of intestine

176

1.59

1.54

1.3

1.8

2.42

5.26

ug/l

0.91

130

Urticaria and erythema

351

3103

1.13

1.53

1.3

2.96

3.81

ug/l

2.73

311

2812

Benign neoplasm of colon, rectum, anus and anal canal

536

1.28

1.52

1.6

1.2

9.07

2.68

ug/l

0.54

421

Other maltreatment syndromes

142

0.42

1.52

1.8

1.3

1.78

2.89

ug/l

—

129

Benign neoplasm: Colon

567

1.31

1.52

1.4

1.8

11.22

4.13

ug/l

0.43

376

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

690

0.72

1.52

1.2

1.4

12.62

3.70

ug/l

0.50

619

Bacterial pneumoniae

130

1407

0.82

1.52

1.6

1.4

2.80

4.34

ug/l

2.44

112

1244

Benign paroxysmal vertigo

100

791

1.27

1.52

1.3

1.5

2.72

4.46

ug/l

1.55

637

Combinations of oral blood glucose lowering drugs

219

0.50

1.51

1.0

1.8

5.68

7.89

ug/l

—

138

Carcinoma in situ of other and unspecified genital organs

2.18

1.51

1.4

1.3

4.48

2.94

ug/l

—

Colorectal adenocarcinoma

1.83

1.51

2.0

2.1

3.06

8.59

ug/l

—

Internal derangement of knee

185

2180

0.85

1.51

1.3

3.18

3.90

ug/l

0.68

158

1918

Other arthrosis

749

0.77

1.50

1.6

1.5

2.00

5.26

ug/l

1.64

516

Other and unspecified mood [affective] disorders

961

0.76

1.50

1.5

1.3

3.52

4.16

ug/l

0.59

913

Colorectal cancer

146

1.65

1.50

1.8

2.70

5.80

ug/l

0.59

Diaphragmatic hernia

616

1.30

1.49

1.4

1.6

2.72

4.85

ug/l

1.34

449

Osteoporosis

293

1.43

1.49

1.7

3.29

6.12

ug/l

0.64

196

Premature rupture of membranes

532

3544

1.11

1.49

1.2

1.3

3.91

3.17

ug/l

0.57

493

3290

Venous thromboembolism

162

1312

1.20

1.49

1.7

1.4

2.55

4.09

ug/l

2.03

120

1063

Left ventricular outflow tract obstruction (LVOTO), broad definition

234

1.50

1.49

1.4

8.60

5.05

ug/l

0.44

201

Soft tissue disorders

1011

5647

0.93

1.48

1.3

3.22

3.83

ug/l

1.81

915

5158

Melanocytic naevi, other sites/unspecified

436

1.36

1.48

1.4

1.3

2.46

3.92

ug/l

1.35

398

Polyneuropathies and other disorders of the peripheral nervous system

292

1.44

1.47

2.3

1.5

5.42

3.97

ug/l

0.20

231

Acute appendicitis

491

5120

0.90

1.46

1.3

4.36

3.40

ug/l

0.48

432

4590

Aortic valve malfunction, age under 60 years

163

1.60

1.46

1.2

1.5

4.27

5.66

ug/l

0.33

134

Fissure and fistula of anal and rectal regions

120

975

1.23

1.45

1.2

1.4

2.94

4.16

ug/l

1.13

103

842

Medical observation and evaluation for suspected diseases and conditions

637

2975

1.10

1.45

1.3

3.38

3.99

ug/l

0.71

561

2706

Migraine

717

5612

1.09

1.44

1.3

3.45

3.71

ug/l

0.39

654

5141

Eating disorders

241

2089

1.16

1.44

1.4

1.3

4.23

3.71

ug/l

0.38

233

1988

Precocious puberty

1.92

1.44

1.6

1.4

2.36

3.08

ug/l

0.64

Eating disorder

236

2044

1.16

1.44

1.3

3.82

3.75

ug/l

0.05

228

1947

Falls/tendency to fall

1057

5676

0.93

1.44

1.3

3.28

3.74

ug/l

1.30

942

5150

Epilepsy

142

1703

0.83

1.43

1.3

3.14

4.30

ug/l

1.97

123

1536

Fibromyalgia

659

0.72

1.43

1.3

1.4

2.01

3.56

ug/l

2.62

580

Haemangioma and lymphangioma, any site

328

1.41

1.42

1.5

1.2

2.72

3.19

ug/l

0.38

294

Childhood asthma (age<16)

287

2588

0.88

1.42

1.2

1.3

3.77

3.80

ug/l

0.03

273

2490

Thyrotoxicosis with diffuse goitre

116

943

1.23

1.42

1.2

1.3

2.39

3.76

ug/l

2.18

100

833

Emotional disorders and disorders of social functioning with onset specific to childhood

1004

0.78

1.41

1.4

1.3

4.28

4.46

ug/l

0.14

965

Symptoms and signs involving speech and voice

149

1242

1.20

1.41

1.5

1.4

3.22

4.01

ug/l

0.40

125

1038

Transport accidents

419

4130

0.90

1.41

1.2

1.3

4.08

3.61

ug/l

0.27

391

3793

Childhood asthma (age<16), excluding more controls

287

2585

0.88

1.40

1.2

1.3

3.77

3.79

ug/l

0.03

273

2489

Bleeding

245

2051

0.87

1.40

1.4

3.79

4.57

ug/l

0.48

207

1726

Disorders of lacrimal system

221

1906

1.16

1.40

1.3

1.4

2.63

4.20

ug/l

2.49

182

1622

Postpartum haemorrhage due to retained placenta

221

1911

1.16

1.39

1.2

1.3

2.88

3.88

ug/l

2.74

200

1771

Umbilical hernia

951

0.78

1.38

1.2

1.3

2.67

3.84

ug/l

1.19

841

Complications of procedures, not elsewhere classified

560

4414

1.10

1.38

1.4

1.3

3.41

3.47

ug/l

0.04

468

3913

Gonarthrosis, primary, with knee surgery

286

0.63

1.37

3.7

2.3

18.17

17.97

ug/l

—

Obesity related asthma

108

1327

0.81

1.37

1.4

3.83

4.21

ug/l

0.13

1126

Diseases of peritoneum

231

1.48

1.36

1.4

1.5

1.64

4.05

ug/l

1.35

194

Other or unspecified ileus, impaction or obstruction

239

1.47

1.36

1.1

1.6

1.62

4.37

ug/l

1.49

183

Other chronic obstructive pulmonary disease, including avohilmo

428

0.70

1.34

1.1

1.8

3.73

5.75

ug/l

0.58

290

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

324

1.39

1.33

2.1

1.4

3.11

4.38

ug/l

0.69

284

Adenocarcinoma and papilloma adenocarcinoma of rectum

2.13

1.33

1.5

1.7

0.80

2.92

ug/l

—

Malignant neoplasm of rectum

2.13

1.33

1.5

1.7

0.80

3.00

ug/l

—

Urticaria

305

2703

1.13

1.33

1.3

3.06

3.86

ug/l

2.13

277

2460

Other systemic involvement of connective tissue (FG)

111

1345

0.82

1.32

1.2

1.4

2.52

3.99

ug/l

2.27

1148

Thyroiditis

419

1.34

1.32

1.5

1.4

4.23

3.85

ug/l

0.06

377

Temporomandibular joint disorders

178

1519

1.18

1.32

1.3

3.17

3.69

ug/l

0.36

166

1381

Benign neoplasm of other and ill-defined parts of digestive system

316

1.39

1.32

1.5

1.6

4.13

4.39

ug/l

0.08

247

Nausea and vomiting

190

1602

1.17

1.32

1.4

1.3

3.72

3.85

ug/l

0.07

169

1471

Viral hepatitis, IBD co-morbidity

428

0.67

1.32

1.3

2.95

3.91

ug/l

0.61

396

Other condition

718

0.75

1.32

1.4

4.70

4.11

ug/l

0.15

659

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

233

1.46

1.31

1.4

1.2

1.75

2.70

ug/l

1.62

204

IBD patients in KELA-register

148

1755

0.84

1.31

1.2

1.3

2.34

3.80

ug/l

4.91

138

1594

Accidents

818

4416

0.93

1.31

1.3

3.86

3.73

ug/l

0.11

736

3991

Disorders of synovium and tendon

331

3341

0.89

1.31

1.3

3.19

3.74

ug/l

0.63

284

2944

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

397

1.29

1.30

1.3

1.1

3.21

2.72

ug/l

0.42

294

Other follicular disorders

497

0.70

1.30

1.2

1.3

2.42

3.40

ug/l

0.91

462

Inflammatory bowel disease, strict (require KELA)

148

1753

0.84

1.30

1.2

1.3

2.34

3.75

ug/l

4.70

138

1594

Erysipelas

992

0.80

1.29

1.4

1.5

2.10

4.54

ug/l

2.97

793

Atrophic disorders of skin

578

1.28

1.29

1.3

1.4

2.67

3.79

ug/l

1.24

493

Symptoms and signs involving the urinary system

276

2417

0.88

1.29

1.3

1.4

3.68

3.97

ug/l

0.19

238

2080

Phakomatoses, not elsewhere classified

2.03

1.28

2.2

1.4

2.17

3.45

ug/l

0.88

Labour and delivery complicated by fetal stress [distress]

621

3815

1.09

1.27

1.3

1.2

3.35

3.36

ug/l

0.01

582

3545

Malignant neoplasm of endocrine gland

244

1.44

1.25

1.5

2.04

4.05

ug/l

0.97

208

Psoriatic arthropathies

340

0.65

1.25

1.1

1.3

3.00

3.80

ug/l

0.30

285

Other symptoms and signs involving general sensations and perceptions

158

0.50

1.25

1.4

3.61

3.18

ug/l

—

142

Hypertrophy of tongue papillae

2.24

1.25

1.3

1.2

2.47

3.07

ug/l

—

Emotional disorders starting during childhood or adolescence

925

0.79

1.24

1.4

1.3

4.34

4.49

ug/l

0.10

888

Viral infections characterized by skin and mucous membrane lesions

284

2516

1.13

1.24

1.4

1.3

4.11

3.84

ug/l

0.08

246

2268

Disorders of breast

400

4096

0.90

1.24

1.4

1.3

3.87

3.55

ug/l

0.11

332

3599

Abnormal findings on diagnostic imaging of other body structures

346

1.36

1.24

2.3

1.5

4.07

4.27

ug/l

0.05

289

Placenta praevia

772

1.24

1.23

1.2

1.3

2.69

3.16

ug/l

0.59

713

Injuries to the hip and thigh

129

1409

0.84

1.23

1.4

3.88

4.39

ug/l

0.21

112

1230

Disorders of ocular muscles, binocular movement, accommodation and refraction

472

4269

1.10

1.23

1.3

4.00

3.88

ug/l

0.10

429

3905

Superficial injury of lower leg

157

1839

0.85

1.22

1.3

3.44

3.82

ug/l

0.53

133

1682

Malignant neoplasm of digestive organs

233

1.44

1.22

1.6

1.8

2.55

6.95

ug/l

0.81

145

Effects of heat and light

2.66

1.22

1.2

1.1

5.68

3.99

ug/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

842

0.78

1.21

1.1

1.4

2.74

4.35

ug/l

2.27

758

Preparation and fitting of bite rail to mouth

108

890

1.22

1.20

1.5

1.3

3.99

3.63

ug/l

0.11

800

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

213

1.46

1.20

1.3

1.2

1.84

2.71

ug/l

1.28

187

Reactive arthropathies

374

1.34

1.20

1.6

1.3

4.96

3.98

ug/l

0.18

329

Sulfasalazine

139

1642

0.85

1.20

1.2

1.4

3.34

3.88

ug/l

0.53

120

1433

Mental and behavioural disorders due to opioids

323

0.65

1.19

1.3

1.2

2.82

3.37

ug/l

0.36

305

Heterophoria

684

1.25

1.19

1.2

1.3

4.66

4.16

ug/l

0.14

639

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

289

1.39

1.19

1.4

2.15

4.07

ug/l

1.32

254

Reactive arthropathies, FINNGEN

332

1.36

1.18

1.7

1.4

5.27

4.06

ug/l

0.20

299

Pulmonary heart disease

488

1.29

1.18

1.5

2.56

4.91

ug/l

1.24

394

Other and unspecified drugs and medicaments

358

1.35

1.18

1.5

1.4

2.73

4.15

ug/l

1.02

321

Benign neoplasm of mouth and pharynx

281

1.39

1.18

1.2

1.5

2.05

4.14

ug/l

1.47

242

Asthma-related infections

364

3961

0.90

1.17

1.3

3.77

4.08

ug/l

0.25

326

3547

Asthma, hospital admission 2, infections

364

3961

0.90

1.17

1.3

3.77

4.08

ug/l

0.25

326

3547

Organic, including symptomatic, mental disorders

345

0.71

1.17

2.4

1.7

2.92

5.51

ug/l

0.82

257

Cerebrovascular diseases (FINNGEN)

658

0.79

1.17

2.1

1.4

4.73

3.78

ug/l

0.24

521

Pulmonary embolism

489

1.29

1.17

1.5

2.56

4.90

ug/l

1.23

395

Failed induction of labour

154

1320

1.18

1.16

1.2

1.3

2.99

3.56

ug/l

0.94

142

1251

Fenamates

176

1021

1.17

1.16

1.3

4.87

3.84

ug/l

0.18

159

943

Bacterial pneumonia, not elsewhere classified

124

1305

0.84

1.15

1.6

1.4

2.90

4.38

ug/l

2.06

106

1150

Juvenile osteochondrosis

300

1.38

1.15

1.2

1.4

3.47

3.37

ug/l

0.07

280

Symptoms and signs involving the nervous and musculoskeletal systems

288

3221

0.89

1.15

1.3

1.4

3.92

4.02

ug/l

0.05

246

2850

Emotional disorders starting during childhood or adolecense, excluding more controls

903

0.80

1.15

1.4

1.2

4.34

4.47

ug/l

0.09

871

Acidosis

2.51

1.15

1.8

1.4

1.94

3.30

ug/l

—

Neurological diseases

966

5179

0.94

1.14

1.3

3.85

3.78

ug/l

0.09

881

4755

Alcohol abuse, main dg, excluding more controls

779

0.78

1.14

1.3

3.10

4.14

ug/l

1.30

723

Chronic viral hepatitis

343

0.67

1.13

1.4

1.3

2.32

3.00

ug/l

1.00

317

COPD

333

0.69

1.13

1.2

1.8

2.68

6.74

ug/l

1.19

225

Benign neoplasm of colon, rectum, anus and anal canal

709

1.22

1.13

1.6

1.7

9.07

5.14

ug/l

0.28

491

Disorders of vestibular function (Vertigo)

159

1355

1.17

1.13

1.6

1.4

3.08

4.15

ug/l

1.15

123

1090

Other chronic obstructive pulmonary disease

306

0.68

1.13

1.2

1.7

2.97

6.38

ug/l

0.84

205

Other viral diseases, not elsewhere classified

150

1279

1.17

1.13

1.3

3.62

4.38

ug/l

0.79

132

1165

Car occupant injured in other and unspecified transport accidents

153

1781

0.86

1.13

1.2

1.3

5.20

3.63

ug/l

0.37

148

1652

Other symptoms and signs involving the urinary system

233

1.42

1.12

1.3

1.5

7.08

3.47

ug/l

0.44

204

Hypo-osmolality and hyponatraemia

199

1.45

1.12

1.3

1.6

3.29

5.04

ug/l

0.48

145

Bell's palsy

476

1.28

1.11

1.8

1.4

3.07

4.05

ug/l

0.68

425

Benign neoplasm: Sigmoid colon

143

1.54

1.11

1.7

1.9

27.01

6.21

ug/l

0.43

Other CVD

217

1.43

1.10

1.8

1.6

2.72

4.62

ug/l

0.75

169

Arthropathic psoriasis

329

0.67

1.10

1.1

1.4

2.90

3.78

ug/l

0.33

276

Myeloproliferative diseases (CML excluded)

1.67

1.10

1.1

1.7

2.45

5.23

ug/l

—

Dysphagia

619

1.25

1.10

1.3

1.4

5.94

3.85

ug/l

0.28

527

Allergic urticaria

647

1.24

1.09

1.3

2.88

4.19

ug/l

1.75

596

Striking against or struck by other objects

195

2224

0.87

1.09

1.3

3.17

3.96

ug/l

2.00

184

2048

Deep bite

715

1.22

1.09

1.5

1.4

5.43

4.91

ug/l

0.15

665

Trochanteric bursitis

352

0.68

1.09

1.1

1.7

2.95

5.29

ug/l

0.76

267

Ischaemic heart disease, wide definition

543

0.79

1.09

2.0

1.8

2.06

7.99

ug/l

1.83

315

Hernia of abdominal wall, postoperative

398

1.31

1.09

2.8

1.2

2.15

3.02

ug/l

1.10

341

Certain infectious and parasitic diseases

1015

4785

1.06

1.09

1.4

1.3

3.66

3.82

ug/l

0.16

909

4351

Stroke, excluding SAH

485

0.77

1.08

2.4

1.8

6.50

5.57

ug/l

0.12

332

Nonsuppurative otitis media

354

3369

0.91

1.08

1.2

1.3

3.77

3.99

ug/l

0.45

339

3229

Seropositive rheumatoid arthritis, strict definition

479

0.73

1.08

1.1

1.5

4.02

3.87

ug/l

0.05

400

Protozoal diseases

1.87

1.07

2.0

1.2

2.15

3.18

ug/l

0.60

Benign neoplasm: Adrenal gland

1.69

1.07

1.4

1.7

1.28

7.56

ug/l

—

Haemangioma, any site

321

1.34

1.07

1.5

1.4

2.85

4.06

ug/l

0.64

282

Acute posthaemorrhagic anaemia

1.87

1.07

1.0

1.4

2.81

3.35

ug/l

0.19

Phlebitis and thrombophlebitis (not including DVT)

693

1.23

1.07

1.6

1.3

2.35

4.18

ug/l

1.44

581

Other disorders of central nervous system

1.95

1.07

1.4

2.22

3.41

ug/l

—

Recurring oral aphthae, including avohilmo

767

1.22

1.06

1.3

1.4

4.13

3.97

ug/l

0.06

699

Iron deficiency

332

1.34

1.06

1.3

2.41

3.49

ug/l

2.47

311

Abnormal results of function studies

322

1.34

1.05

1.3

1.4

3.64

4.23

ug/l

0.26

285

Oral lichen ruber planus, including avohilmo

113

1.60

1.05

1.1

1.7

3.01

5.91

ug/l

0.55

Benign neoplasm of breast

650

1.23

1.05

1.6

1.4

2.79

4.07

ug/l

1.48

569

Myeloproliferative diseases

113

1.60

1.05

1.1

1.7

2.66

5.94

ug/l

0.66

Follicular cysts of skin and subcutaneous tissue

668

1.23

1.05

1.3

1.4

2.74

3.79

ug/l

1.16

584

Diabetic retinopathy, strict definition

519

0.76

1.05

1.3

3.52

4.86

ug/l

1.97

474

Ischaemic Stroke, excluding all haemorrhages

422

0.75

1.05

2.7

1.7

4.53

5.94

ug/l

0.25

287

Mental and behavioural disorders due to sedatives or hypnotics

348

0.69

1.04

1.5

1.3

2.91

3.28

ug/l

0.20

319

Persons with potential health hazards related to communicable diseases

587

5409

1.08

1.04

1.3

3.39

3.60

ug/l

0.50

551

5031

Injury of muscle and tendon at wrist and hand level

418

0.72

1.04

1.4

2.67

4.03

ug/l

1.07

366

COPD (mode)

239

0.66

1.03

1.2

1.9

2.91

8.04

ug/l

1.04

157

Lesion of ulnar nerve

376

1.31

1.02

1.3

1.4

2.87

4.09

ug/l

0.73

319

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS